Identification of growth arrest and DNA-damage- inducible gene β (GADD45β) as a novel tumor suppressor in pituitary gonadotrope tumors

Endocrinology

Volumn 152, Issue 10, 2011, Pages 3603-3613

  Michaelis, Katherine A ^a   Knox, Aaron J ^a   Xu, Mei ^a,b   Kiseljak Vassiliades, Katja ^a,b   Edwards, Michael G ^a   Geraci, Mark ^a   Kleinschmidt DeMasters, B K ^a   Lillehei, Kevin O ^a   Wierman, Margaret E ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEOPROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; PHORBOL 12 MYRISTATE 13 ACETATE INDUCED PROTEIN; PROTEIN P21; PROTEIN P53; PROTEIN REPRIMO; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HYPOPHYSIS TUMOR; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, DIFFERENTIATION; CELL LINE; DNA DAMAGE; FEMALE; GENES, P53; GONADOTROPHS; HUMANS; MALE; MICE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PITUITARY NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 80053159541     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-0109     Document Type: Article

References (42)

1. Asa SL, Ezzat S 2009 The pathogenesis of pituitary tumors. Annu Rev Pathol 4:97-126
2. Melmed S 2003 Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest 112:1603-1618 (Pubitemid 38063716)
3. Melmed S 2008 Update in pituitary disease. J Clin Endocrinol Metab 93:331-338 (Pubitemid 351240799)
4. Alexander JM, Biller BM, Bikkal H, Zervas NT, Arnold A, Klibanski A 1990 Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest 86:336-340 (Pubitemid 20227010)
5. Ridgway EC, Klibanski A, Ladenson PW, Clemmons D, Beitins IZ, McArthur JW, Martorana MA, Zervas NT 1981 Pure α-secreting pituitary adenomas. N Engl J Med 304:1254-1259
6. Cretu A, Sha X, Tront J, Hoffman B, Liebermann DA 2009 Stress sensor Gadd45 genes as therapeutic targets in cancer. Cancer Ther 7:268-276
7. Higgs MR, Lerat H, Pawlotsky JM 2010 Downregulation of Gadd45 β expression by hepatitis C virus leads to defective cell cycle arrest. Cancer Res 70:4901-4911
8. Zerbini LF, Libermann TA 2005 Life and death in cancer. GADD45 α and γ are critical regulators of NF-κB mediated escape from programmed cell death. Cell Cycle 4:18-20 (Pubitemid 41038917)
9. Ying J, Srivastava G, Hsieh WS, Gao Z, Murray P, Liao SK, Ambinder R, Tao Q 2005 The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin Cancer Res 11:6442-6449 (Pubitemid 41338980)
10. Zhang X, Sun H, Danila DC, Johnson SR, Zhou Y, Swearingen B, Klibanski A 2002 Loss of expression of GADD45 γ, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis. J Clin Endocrinol Metab 87:1262-1267 (Pubitemid 36121097)
11. Carrier F, Smith ML, Bae I, Kilpatrick KE, Lansing TJ, Chen CY, Engelstein M, Friend SH, Henner WD, Gilmer TM, et al. 1994 Characterization of human Gadd45, a p53-regulated protein. J Biol Chem 269:32672-32677
12. Zhang W, Bae I, Krishnaraju K, Azam N, Fan W, Smith K, Hoffman B, Liebermann DA 1999 CR6: A third member in the MyD118 and Gadd45 gene family which functions in negative growth control. Oncogene 18:4899-4907 (Pubitemid 29425296)
13. Jolliffe IT 2002 Principal component analysis. New York: Springer
14. Albacete A, Ghanem ME, Dodd IC, Pérez-Alfocea F 2010 Principal component analysis of hormone profiling data suggests an important role for cytokinins in regulating leaf growth and senescence of salinized tomato. Plant Signal Behav 5:45-48
15. Wu ZJ, Irizarry RA, Gentleman R, Martinez-Murillo F, Spencer F 2004 A model-based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc 99:909-917 (Pubitemid 39665934)
16. Shorts-Cary L, Xu M, Ertel J, Kleinschmidt-Demasters BK, Lillehei K, Matsuoka I, Nielsen-Preiss S, Wierman ME 2007 Bone morphogenetic protein and retinoic acid-inducible neural specific protein-3 is expressed in gonadotrope cell pituitary adenomas and induces proliferation, migration, and invasion. Endocrinology 148:967-975
17. Li L 2010 Dimension reduction for high-dimensional data. Methods Mol Biol 620:417-434
18. Levy A, Hall L, Yeudall WA, Lightman SL 1994 p53 gene mutations in pituitary adenomas: rare events. Clin Endocrinol (Oxf) 41:809-814
19. Zerbini LF, Libermann TA 2005 GADD45 deregulation in cancer: frequently methylated tumor suppressors and potential therapeutic targets. Clin Cancer Res 11:6409-6413 (Pubitemid 41338976)
20. Giorgi RR, Correa-Giannella ML, Casarini AP, Machado MC, Bronstein MD, Cescato VA, Giannella-Neto D 2005 Metallothionein isoform 3 gene is differentially expressed in corticotropin-producing pituitary adenomas. Neuroendocrinology 82:208-214
21. Evans CO, Young AN, Brown MR, Brat DJ, Parks JS, Neish AS, Oyesiku NM 2001 Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab 86:3097-3107 (Pubitemid 32673472)
22. Morris DG, Musat M, Czirják S, Hanzély Z, Lillington DM, Korbonits M, Grossman AB 2005 Differential gene expression in pituitary adenomas by oligonucleotide array analysis. Eur J Endocrinol 153:143-151 (Pubitemid 41030525)
23. Altenberger T, Bilban M, Auer M, Knosp E, Wolfsberger S, Gartner W, Mineva I, Zielinski C, Wagner L, Luger A 2006 Identification of DLK1 variants in pituitary and neuroendocrine tumors. Biochem Biophys Res Commun 340:995-1005 (Pubitemid 43053925)
24. Ruebel KH, Leontovich AA, Jin L, Stilling GA, Zhang H, Qian X, Nakamura N, Scheithauer BW, Kovacs K, Lloyd RV 2006 Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression. Endocrine 29:435-444 (Pubitemid 44358833)
25. Elston MS, Gill AJ, Conaglen JV, Clarkson A, Shaw JM, Law AJ, Cook RJ, Little NS, Clifton-Bligh RJ, Robinson BG, McDonald KL 2008 Wnt pathway inhibitors are strongly down-regulated in pituitary tumors. Endocrinology 149:1235-1242 (Pubitemid 351397935)
26. Hussaini IM, Trotter C, Zhao Y, Abdel-Fattah R, Amos S, Xiao A, Agi CU, Redpath GT, Fang Z, Leung GK, Lopes MB, Laws Jr ER 2007 Matrix metalloproteinase-9 is differentially expressed in non-functioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. Am J Pathol 170:356-365 (Pubitemid 47339213)
27. Galland F, Lacroix L, Saulnier P, Dessen P, Meduri G, Bernier M, Gaillard S, Guibourdenche J, Fournier T, Evain-Brion D, Bidart JM, Chanson P 2010 Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis. Endocr Relat Cancer 17:361-371
28. Moreno CS, Evans CO, Zhan X, Okor M, Desiderio DM, Oyesiku NM 2005 Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Res 65:10214-10222 (Pubitemid 41743713)
29. Wierinckx A, Auger C, Devauchelle P, Reynaud A, Chevallier P, Jan M, Perrin G, Fèvre-Montange M, Rey C, Figarella-Branger D, Raverot G, Belin MF, Lachuer J, Trouillas J 2007 A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors. Endocr Relat Cancer 14:887-900 (Pubitemid 350074076)
30. Suliman M, Royds J, Cullen D, Timperley W, Powell T, Battersby R, Jones TH 2001 Mdm2 and the p53 pathway in human pituitary adenomas. Clin Endocrinol (Oxf) 54:317-325 (Pubitemid 32234195)
31. Hentschel SJ, McCutcheon E, Moore W, Durity FA 2003 P53 and MIB-1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas. Can J Neurol Sci 30:215-219 (Pubitemid 37064515)
32. Oliveira MC, Marroni CP, Pizarro CB, Pereira-Lima JF, Barbosa- Coutinho LM, Ferreira NP 2002 Expression of p53 protein in pituitary adenomas. Braz J Med Biol Res 35:561-565 (Pubitemid 34568224)
33. Botelho CH, Magalhães AV, Mello PA, Schmitt FC, Casulari LA 2006 Expression of p53, Ki-67 and c-erb B2 in growth hormone-and/or prolactin-secreting pituitary adenomas. Arq Neuropsiquiatr 64:60-66
34. Schreiber S, Saeger W, Lüdecke DK 1999 Proliferation markers in different types of clinically non-secreting pituitary adenomas. Pituitary 1:213-220
35. Buckley N, Bates AS, Broome JC, Strange RC, Perrett CW, Burke CW, Clayton RN 1994 p53 Protein accumulates in Cushings adenomas and invasive non-functional adenomas. J Clin Endocrinol Metab 79:1513-1516 (Pubitemid 24369875)
36. Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws Jr ER 1996 p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 38:765-770; discussion 770-761
37. Pagotto U, Arzberger T, Ciani E, Lezoualc'h F, Pilon C, Journot L, Spengler D, Stalla GK 1999 Inhibition of Zac1, a new gene differentially expressed in the anterior pituitary, increases cell proliferation. Endocrinology 140:987-996 (Pubitemid 29058240)
38. Pagotto U, Arzberger T, Theodoropoulou M, Grübler Y, Pantaloni C, Saeger W, Losa M, Journot L, Stalla GK, Spengler D 2000 The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas. Cancer Res 60:6794-6799 (Pubitemid 32059140)
39. Theodoropoulou M, Stalla GK, Spengler D 2010 ZAC1 target genes and pituitary tumorigenesis. Mol Cell Endocrinol 326:60-65
40. Hoffman B, Liebermann DA 2009 Gadd45 modulation of intrinsic and extrinsic stress responses in myeloid cells. J Cell Physiol 218:26-31
41. Ibragimova I, Ibanez de Caceres I, Hoffman AM, Potapova A, Dulaimi E, Al-Saleem T, Hudes GR, Ochs MF, Cairns P 2010 Global reactivation of epigenetically silenced genes in prostate cancer. Cancer Prev Res (Phila) 3:1084-1092
42. Bahar A, Bicknell JE, Simpson DJ, Clayton RN, Farrell WE 2004 Loss of expression of the growth inhibitory gene GADD45γ, in human pituitary adenomas, is associated with CpG island methylation. Oncogene 23:936-944 (Pubitemid 38250939)